Amanta Healthcare bulk deals, insider trading and stake changes
NSE: AMANTABSE: 544502Pharmaceuticals & BiotechnologySmall Cap
Last close ₹163.07down ₹1.81 (1.10%)BSE ₹163.20
Share price at the NSE close on 23 Oct 2026. Previous close ₹164.88.
52-week range of traded prices to 23 Oct 2026
₹92.00Low, 16 Mar 2026₹209.95High, 10 Sep 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹633 Cr1,889th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 5 Aug 2026
- 43.1
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹2.63 crore of one-off items, the largest of them in the quarter to Sep 2025.
- 36.6
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 29 May 2026
- 2.9
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the latest balance sheet's; the one a year before is not on record. The filing of 5 Aug 2026
- 6.7%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹2.63 crore of one-off items, the largest of them in the quarter to Sep 2025.
- 7.9%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 5 Aug 2026
- 9.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 29 May 2026
- 1.06
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 1,21,12048.9% delivered
Promoter and insider buying and selling
Trades made since 23 Oct 2025.Amanta Healthcare promoter holding
Bought on the marketBought on the market. The value each filer stated for its purchases on the exchange, added up; gifts, transfers and pledges are not counted. A purchase filed with no value is counted under the sum, not in it. Sold on the marketSold on the market. The value each filer stated for its sales on the exchange, added up; gifts, transfers and pledges are not counted. A sale filed with no value is counted under the sum, not in it.
- Promoters and promoter group4 purchases, 1 sale₹1.10 Cr₹0.08 CrNetNet. The value bought on the market less the value sold, over the trades whose filers stated a value.₹1.02 Cr5 off-market moves
- Others1 purchase, 0 sales₹0.15 CrNo saleNetNet. The value bought on the market less the value sold, over the trades whose filers stated a value.₹0.15 Cr
Bought and sold count trades on the market only. A pledge is shares given to a lender as security for a loan; a lender invokes it by selling them.
Amanta Healthcare insider trading
All 25 disclosures on record.Insider trading, all companies
Sep 2026
- Pravinchandra Dhanjibhai Mehta17,32,763sharesGave · Promoter Group · 30 Sep 2026 · Gift · stake 4.72% before, 0.26% after
- Pravinchandra Dhanjibhai Mehta₹2.86 Cr1,50,400 sharesGave · Promoter Group · 28 Sep 2026 · disclosed 29 Sep · Inter-se-Transfer · stake 5.11% before, 4.72% after
- Kirit Ambalal Desai₹2.86 Cr1,50,400 sharesReceived · Promoter Group · 28 Sep 2026 · disclosed 29 Sep · Inter-se-Transfer · stake 2.90% before, 3.29% after
Jun 2026
- Bhavesh Girishbhai Patel₹0.02 Cr1,000 sharesReceived · Promoter and Director · 30 Jun 2026 · Off Market · stake 16.31% before, 16.31% after
- Kirit Ambalal Desai₹0.02 Cr1,000 sharesGave · Promoter Group · 30 Jun 2026 · Off Market · stake 2.91% before, 2.90% after
- JITENDRAKUMAR PATEL₹0.06 Cr4,200 sharesBought · Promoter · 18 Jun 2026 · disclosed 24 Jun
- Bhavesh Girishbhai Patel₹0.07 Cr4,635 sharesBought · Promoter and Director · 17 Jun 2026 · stake 16.29% before, 16.31% after
- JITENDRAKUMAR PATEL₹0.18 Cr12,000 sharesBought · Promoter · 16 Jun 2026 · disclosed 22 Jun
- Jitendrakumar Jashbhai Patel₹0.24 Cr16,200 sharesBought · Promoter · 16 Jun 2026 · disclosed 19 Jun · stake 8.98% before, 9.02% after
- Kirit Ambalal Desai₹0.08 Cr5,000 sharesSold · Promoter Group · 15 Jun 2026 · disclosed 17 Jun · stake 2.92% before, 2.91% after
Mar 2026
- Bhavesh Girishbhai Patel₹0.28 Cr28,800 sharesBought · Promoter & Director · 27 Mar 2026 · disclosed 31 Mar · stake 16.22% before, 16.29% after
- Dympal Jain₹0.15 Cr15,675 sharesBought · Directors Immediate Relative · 19 Mar 2026 · disclosed 25 Mar · held 1 before, holds 15,676 after, stake 0.04% after
Feb 2026
- BHAVESH GIRISHBHAI PATEL₹25,924250 sharesBought · Promoter · 27 Feb 2026 · disclosed 7 Apr
- BHAVESH GIRISHBHAI PATEL₹0.50 Cr47,901 sharesBought · Promoter · 26 Feb 2026 · disclosed 7 Apr
- Bhavesh Girishbahi Patel₹0.50 Cr48,151 sharesBought · Promoter and Director · 26 Feb 2026 · disclosed 27 Feb · stake 16.10% before, 16.22% after
Dec 2025
- SHAILESH SHAH₹0.08 Cr7,250 sharesBought · Designated Person · 22 Dec 2025 · disclosed 31 Dec
- SHAILESH SHAH₹55,640500 sharesSold or invoked · Designated Person · 22 Dec 2025 · disclosed 31 Dec
- SHAILESH SHAH₹0.06 Cr6,000 sharesBought · Designated Person · 17 Dec 2025 · disclosed 23 Dec
- SHAILESH SHAH₹0.04 Cr4,000 sharesSold or invoked · Designated Person · 17 Dec 2025 · disclosed 23 Dec
- SHAILESH SHAH₹0.10 Cr9,738 sharesBought · Designated Person · 9 Dec 2025 · disclosed 19 Dec
- SHAILESH SHAH₹1041 sharesSold or invoked · Designated Person · 9 Dec 2025 · disclosed 19 Dec
- SHAILESH SHAH₹0.05 Cr5,000 sharesBought · Designated Person · 5 Dec 2025 · disclosed 10 Dec
- SHAILESH SHAH₹0.10 Cr10,000 sharesBought · Designated Person · 4 Dec 2025 · disclosed 9 Dec
Nov 2025
- SHAILESH SHAH₹0.17 Cr15,700 sharesBought · Designated Person · 10 Nov 2025 · disclosed 5 Dec
- SHAILESH SHAH₹12,270100 sharesSold or invoked · Designated Person · 10 Nov 2025 · disclosed 5 Dec
Trades by the company's promoters, directors, key managers, employees and their relatives, as each disclosed them. Value is what the filer stated; the mode is shown where the shares moved off the market.
Amanta Healthcare stake sales and purchases
All 5 disclosures on record.
Sep 2026
- SoldPravinchandra Dhanjibhai Mehta · promoter4.46% of the company17,32,763 sharesholds 0.26% after30 Sep 2026 · filed under the 2% rule · Inter-se transfer
- SoldPravinchandra Dhanjibhai Mehta · promoter0.39% of the company1,50,400 sharesholds 4.72% after28 Sep 2026 · filed under the 2% rule · Inter-se transfer
- AcquiredKirit Amablal Desai · promoter0.39% of the company1,50,400 sharesholds 3.29% after28 Sep 2026 · filed under the 2% rule
Jun 2026
- AcquiredBhavesh G Patel · promoter1,000 sharesholds 16.31% after30 Jun 2026 · filed under the 2% rule · Inter-se transfer
Mar 2026
- AcquiredBandhan Mutual Fund0.06% of the company21,603 sharesholds 5.01% after25 Mar 2026 · filed under the 5% rule · Open Market
The 5% rule: an investor discloses on reaching 5% of the company. The 2% rule: a holder of 5% or more discloses each change of 2% or more, including one that takes it below 5%. A transfer exempt from an open offer, the offer to buy from every other shareholder that a large purchase otherwise brings, is disclosed too. Each line shows what its filing states, which can be a smaller change than its rule names.
Amanta Healthcare bulk deals
Last 12 months, since 23 Oct 2025: 12 bulk deals, ₹22 Cr bought and ₹21 Cr sold Bought and sold in deals. Each deal's shares times its price, added up for the buyers and apart for the sellers, so a block deal, which names both, counts on each side.Today's bulk and block deals, all companies
ValueValue of a deal. The shares traded times the deal's price.Per cent of the companyPer cent of the company. The shares traded as a percentage of all the company's shares in issue on the day of the deal.
Thursday 11 Jun 20264 firms · ₹17 Cr bought · ₹17 Cr soldNet nil
- Both waysNK SECURITIES RESEARCH PRIVATE LIMITEDBought 3,80,749 at ₹156.07Sold 3,80,749 at ₹156.240.98% of the companyNet nil₹5.94 Cr bought
- Both waysSILVERLEAF CAPITAL SERVICES PRIVATE LIMITEDBought 2,62,235 at ₹159.04Sold 2,62,235 at ₹158.850.68% of the companyNet nil₹4.17 Cr bought
- Both waysALPHAGREP SECURITIES PRIVATE LIMITEDBought 2,18,854 at ₹156.56Sold 2,18,854 at ₹156.350.56% of the companyNet nil₹3.43 Cr bought
- Both waysBLITZQUANT RESEARCH LLPBought 2,05,983 at ₹158.85Sold 2,05,983 at ₹158.960.53% of the companyNet nil₹3.27 Cr bought
Thursday 16 Apr 20261 firm · ₹2.66 Cr bought · ₹2.70 Cr soldNet sold ₹0.04 Cr
- Both waysMANSI SHARE AND STOCK BROKING PRIVATE LIMITEDBought 2,16,504 at ₹123.09Sold 2,16,504 at ₹124.860.56% of the companyNet nil₹2.66 Cr bought
Monday 10 Nov 20251 firm · ₹2.56 Cr bought · ₹1.32 Cr soldNet bought ₹1.24 Cr
- Both waysMANSI SHARE AND STOCK BROKING PRIVATE LIMITEDBought 2,06,367 at ₹123.88Sold 1,10,000 at ₹120.050.53% of the companyNet +96,367 shares₹2.56 Cr bought
Wednesday 10 Sep 20252 firms · ₹3.03 Cr bought · ₹3.27 Cr soldNet sold ₹0.24 Cr
- Both waysNAVRATRI SHARE TRADING PRIVATE LIMITED .Bought 8,898 at ₹141.81Sold 2,20,000 at ₹148.820.57% of the companyNet −2,11,102 shares₹0.13 Cr bought
- BoughtAARTH.AIF GROWTH FUNDBought 2,00,000 at ₹145.240.52% of the company₹2.90 Cr
Tuesday 9 Sep 20252 firms · ₹7.94 Cr bought · ₹0.51 Cr soldNet bought ₹7.43 Cr
- Both waysSUNRISE INVESTMENT OPPORTUNITIES FUNDBought 3,18,817 at ₹133.51Sold 37,422 at ₹135.000.82% of the companyNet +2,81,395 shares₹4.26 Cr bought
- BoughtNAVRATRI SHARE TRADING PRIVATE LIMITED .Bought 2,68,602 at ₹137.070.69% of the company₹3.68 Cr
A bulk deal is one client trading half a per cent or more of the shares in a day; a block deal is a large trade in the exchange's separate block window, its buyer and its seller each on a line of their own. A firm that bought and sold the shares the same day is on one line, with its net. All 18 deals on record since listing on 9 Sep 2025.